Latest Breaking News On - பாரத் பயோடெக் சர்வதேச வரையறுக்கப்பட்டவை - Page 6 : comparemela.com

Share this article Share this article NEW YORK, July 28, 2021 /PRNewswire/  Pomerantz LLP announces that a class action lawsuit has been filed against Ocugen, Inc. ( Ocugen or the Company ) (NASDAQ: OCGN) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 21-cv-03182, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Ocugen securities between February 2, 2021, and June 10, 2021, inclusive (the Class Period ), seeking to recover damages for violations of the federal securities laws under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act ), and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

United statesNew yorkAndhra pradeshFrance generalLos angelesAbrahaml pomerantzRoberts willoughbyUnited states district courtDrug administrationBharat biotech international limitedOcugen incExchange commissionSecurities exchangePomerantz firmEastern districtSecurities exchange act